|0.265|| -0.035 / -11.67%|
Services to the Health Industry
Interpace Diagnostics Group, Inc. provides outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the U. S. It also provides other promotional services including clinical educator services, digital communications, teledetailing and with the formation of its new business unit, Interpace BioPharma which provides pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. The company operates its business through the following segments: Commercial Services and Interpace Diagnostics. The Commercial Services segment focuses on providing outsourced pharmaceutical, biotechnology, medical device and diagnostic sales teams to corporate customers. The Interpace Diagnostics segment focuses on developing an commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for better patient diagnosis and management. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.
|Jack E. Stover||President, Chief Executive Officer & Director|
|Graham G. Miao||Chief Financial Officer, Secretary & Treasurer|
|Rhonda De Stefano||Vice President & Associate General Counsel|
|Patrick K. Kane||Vice President & Controller|
|Steve Rynkowski||VP-Learning, Development & Commercial Operations|